Skip to main content

DEXTROAMPHETAMINE-AMPHETAMINE

Tracking # 20-820125

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

DEXTROAMPHETAMINE/AMPHETAMINE BELONGS TO A CLASS OF DRUGS KNOWN AS CENTRAL NERVOUS SYSTEM STIMULANTS. THE DRUG ENFORCEMENT ADMINISTRATION/FOOD AND DRUG ADMINISTRATION CLASSIFIES THESE MEDICATIONS AS SCHEDULE II DRUGS WITH HIGH POTENTIAL FOR ABUSE IN THE UNITED STATES. IMMEDIATE-RELEASE AND SUSTAINED-RELEASE AMPHETAMINE MEDICATIONS ARE FDA-APPROVED TO TREAT ADHD AND NARCOLEPSY IN BOTH THE ADULT AND PEDIATRIC POPULATION. NON-FDA-APPROVED CLINICAL USES FOR DEXTROAMPHETAMINE/AMPHETAMINE INCLUDE CEREBROVASCULAR ACCIDENT. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, APPROVED AND OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS OF DEXTROAMPHETAMINE/AMPHETAMINE, PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM USING THESE MEDICATIONS FOR THEIR INTENDED INDICATIONS.

Subject areas

This course counts toward the state boards and subject areas below.

Florida Board of Osteopathic Medicine

Osteopathic Physician

1h General